Randomisation was stratified on whether patients had current or planned treatment with chemotherapy ; current or planned treatment with hormone therapy ; and whether they had a previous skeletal-related event within the last 3 months or had planned radiotherapy treatment to the bone or planned orthopaedic surgery due to bone metastases .